Avik Roy shapes strategy and mobilizes teams to exceed performance and growth targets. Recent consulting projects include leading the pre- and post-acquisition transition assessment of critical compliance and HR related systems for a pharma manufacturing plant, developing a strategic market assessment to guide growth for a fast-growing life sciences company and advising CEO’s of three technology ventures on growth and capital strategies.

As Senior Vice President of Corporate Development and Operations at Kaplan EduNeering, Mr. Roy turned around three client-facing operating groups. He introduced a rigorous planning discipline, outsourced processing to focus internal attention on customer priorities and fostered team confidence and motivation. After-sales customer satisfaction improved from 50% to 95%. First-call resolution increased from 63% to 96%. Complex client issues were addressed 65% faster. On-schedule project deployments rose by 15%. The group exceeded annual revenue targets by 21% while delivering 67% operating margins with 30% lower headcount.

At Bristol-Myers Squibb he led a clinical trial planning and operations group. His team advanced from a track record that lagged the industry to beating competitive benchmarks by 30%, expediting time-to-market for new products. As an entrepreneur, Mr. Roy co-founded MedAvante, a venture funded company valued at over $70MM that innovated neuroscience clinical trials methods. He led legal, financial and business planning functions.

At Ernst & Young, he structured and closed two e-commerce private placement deals totaling $25MM which expanded client offerings and doubled ROI. Mr. Roy started his business career as an Associate at McKinsey, with a focus on performance improvement at global companies.

He holds an MBA from The Wharton School, MS degrees from Harvard and MIT in planning and design, and a Bachelor of Architecture from The School of Planning and Architecture, the top architecture school in India. He is fluent in Begali and Hindi.